Biotech stocks may be one of the most speculative sectors of the market, but with aging baby boomers creating a surging demand for better care and treatment options, new innovations, and multi-billion-dollar merger and acquisition potential, the sector is not only explosive, but one of the most profitable. Sure, the sector can be plagued by … Continue reading “Two Small Cap Biotech Stocks with Major Catalysts”
